Naive CD4+ T cell subset is the predominant population involved in cytolysis through Fas-ligand in human at birth

Pediatric Research

Volumn 46, Issue 2, 1999, Pages 239-244

  Soulimani, Nabil ^a   Ansart Pirenne, Hélène ^a   Sibony, Olivier ^a   Blot, Philippe ^a   Sterkers, Ghislaine ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; FC RECEPTOR; HYBRID PROTEIN; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BIRTH; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; NEWBORN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD;

EID: 0032809916     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199908000-00018     Document Type: Article

References (35)

1. Lowin B, Hahne M, Mattmann C, Tschopp J 1994 Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:630-652
2. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P 1994 Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530
3. Kojima H, Shinohara N, Hanaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okamura K 1994 Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357-364
4. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang MT, Young JD, Ahmed R, Clark WR 1994 Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 91:10854-10858
5. Henkart PA 1994 Lymphocyte mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343-346
6. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J 1996 Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 183:657-661
7. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H 1994 Cytotoxicity mediated by T cells and natural killer cells in greatly impaired in perforin-deficient mice. Nature 369:16-17
8. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S 1992 Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
9. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K 1994 The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131-136
10. Takahashi T, Tanaka M, Brannan C, Jenkins NA, Copeland NG, Suda T, Nagata S 1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976
11. Fisher GH, Rosenberg FJ, Strauss SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM 1995 Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
12. Sneller MC, Straus SE, Jaffe ES, Fleisher TA, Stetler-Stevenson M, Strober W 1992 A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334-341
13. Fisher GH, Risenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM 1995 Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
14. Le Deist F, Jean-François E, Rieux-Lancat F, Benkerron M, Roberts I, Brousse N, Fisher A 1996 Clinical immunological and pathological consequences of Fas-deficient conditions. Lancet 348:719-723
15. Rieux-Laucat F, Le Deist F, Hiuroz C, Roberts IA, Debatin KM, Fisher A, de Villantray JP 3995 Mutations in Fas associated with human lymphoproliferative syndrome and auto-immunity. Science 268:1347-1349
16. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S 1990 Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620-9624
17. Baumler CB, Bohler T, Herr I, Benner A, Krammer PH, Dehatin KM 1996 Activation of the CD95 (APO-1/Fas) system in T-cells from human immunodeficiency virus type-1-Infected children. Blood 88:1741-1746
18. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S 1997 Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3:387-413
19. Mountz JD, Wu J, Cheng J, Zhou T 1994 Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37:1415-1420
20. Via CS, Nguyen P, Shustov A, Drappa J, Elkon KB 1996 A major role for the Fas pathway in acute graft-versus-host-disease. J Immunol 157:5387-5393
21. + T cells. Pediatr Res 32:81-86
22. Ansart-Pirenne H, Soulimani N, Tartour E, Blot P, Sterkers G 1999 Defective IL2 gene expression in newborns is associated with impaired tyrosine-phosphorylation in T cells. Pediatr Res 45:409-413
23. Beaudouin V, De Vitry N, Hiesse C, Lang G, Bloch J, Legouvello S, Sterkers G 1997 Cytotoxic T lymphocyte changes after HLA-DR match and HLA-DR mismatch transfusion. Transplantation 63:1155-1160
24. Ansart-Pirenne H, Paillard F, De Groote D, Eljaafari A, Le Gac S, Blot P, Franchimont P, Vaquero C, Sterkers G 1995 Detective cytokine expression but adult type T cell receptor. CD8, and P561ck modulation in CD3- or CD2-activated T cells from neonates. Pediatr Res 37:64-69
25. Rouvier E, Luciani MF, Golstein P 1993. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 177:195-200
26. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM 1994 T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469-2476
27. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P 1995 TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 181:781-786
28. Hanabuchi S, Koyanagi M, Kawasaks A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonekara S, Agita Y, Okamura K 1994 Fas and its ligand is a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 91:4930-4934
29. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S 1995 Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806-3813
30. Suda T, Nagata S 1994 Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879
31. + cytotoxic T cells. Proc Natl Acad Sci USA 91:4185-4189
32. + T cell-mediated cytotoxicity. J Immunol 152:1127-1133
33. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Gadwin RG, Smith CA, Ramsdell F, Lynch DH 1995 Fas ligand mediate activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77
34. Azuma M, Phillips JH, Lanier LL 1993 CD28- T lymphocytes. Antigenic and functional properties. J Immunol 150:1147-1159
35. Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaert F, Hamilton C, Mackinnon H, Stokes LT, Munhyeshuli V, Valangendonck F 1992 Age-related changes in human blood lymphocyte subpopulations. J Pediatr 120:216-222